Dr Lenka Munoz

Senior Lecturer
Pharmacology, School of Medical Sciences

D06 - Blackburn Building
The University of Sydney
NSW 2006 Australia

T: +61 2 9351 2315
F: +61 2 9351 3868
E:

Publications

2014 | 2013 | 2012 | 2010

2014

   
  • Gurgis, F., Ziaziaris, W., Munoz, L. (2014), MAPK-activated Protein Kinase 2 (MK2) in Neuroinflammation, Hsp27 Phosphorylation and Cell Cycle: Role and Targeting. Molecular Pharmacology. 85(2), 345-356. [Abstract]

2013

   
  • Eibl, C., Tomassoli, I., Munoz, L., Stokes, C., Papke, R., Gundisch, D. (2013), The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents. Bioorganic & Medicinal Chemistry. 21(23), 7283-7308. [Abstract]
  • Eibl, C., Munoz, L., Tomassoli, I., Stokes, C., Papke, R., G√ľndisch, D. (2013), The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs. Bioorganic & Medicinal Chemistry. 21(23), 7309-7329. [Abstract]
  • Yeung, Y., McDonald, K., Grewal, T., Munoz, L. (2013), Interleukins in glioblastoma pathophysiology: implications for therapy. British Journal of Pharmacology. 168(3), 591-606. [Abstract]

2012

   
  • Yeung, Y., Bryce, N., Adams, S., Braidy, N., Konayagi, M., McDonald, K., Teo, C., Guillemin, G., Grewal, T., Munoz, L. (2012), p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. Journal of Neuro-Oncology. 109, 35-44. [Abstract]

2010

   
  • Munoz, L., Ramsay, E., Manetsch, M., Ge, Q., Peifer, C., Laufer, S., Ammit, A. (2010), Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle. European journal of pharmacology. 635(1-3), 212-8. [Abstract]
  • Munoz, L., Selig, R., Yeung, Y., Peifer, C., Hauser, D., Laufer, S. (2010), Fluorescence polarization binding assay to develop inhibitors of inactive p38alpha mitogen-activated protein kinase. Analytical Biochemistry. 401(1), 125-133. [Abstract]
  • Munoz, L., Ammit, A. (2010), Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology. 58(3), 561-8. [Abstract]